Clinical Report: Physician sentenced for unlawful buprenorphine prescribing
Overview
Dr. Henry Ronald Emery, Jr. was sentenced to 6 months in prison for allowing his DEA registration to be used for unlawful buprenorphine prescriptions. Over a four-year period, he permitted administrative staff to issue more than 25,000 prescriptions without personal patient interaction.
Background
Physicians are critical in ensuring that treatment is conducted responsibly and in compliance with legal and ethical standards.
Data Highlights
No numerical data or trial data available in the source material.
Key Findings
- Dr. Emery allowed his DEA registration number to be used unlawfully.
- He did not personally interact with patients before prescriptions were issued.
- Over 25,000 buprenorphine prescriptions were issued under his name.
- Emery received $452,830 from the organization during the conspiracy.
Clinical Implications
Healthcare professionals must ensure compliance with DEA regulations when prescribing controlled substances.
Conclusion
The sentencing of Dr. Emery highlights the responsibilities of physicians in prescribing practices.
Related Resources & Content
- United States Drug Enforcement Administration, US Attorney’s Office for the Western District of North Carolina, 2023 -- Physician sentenced for unlawful buprenorphine prescribing
- MDSpire News — Former Doc Accused of Murder-for-Hire, Sentenced for Distribution
- MDSpire News — Prescribing Outside the Exam Room
- MDSpire News — Settlement Bars Two From DEA Registration
- JAMA Network Open — High-Deductible Health Plan Enrollment and Buprenorphine Dispensing
- Former Doc Accused of Murder-for-Hire, Sentenced for Distribution
- Prescribing Outside the Exam Room
- Settlement Bars Two From DEA Registration
- Waiver Elimination (MAT Act) | SAMHSA
- ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids
- Emergency Department–Initiated Buprenorphine for Opioid Use Disorder: A Randomized Clinical Trial | JAMA | JAMA Network
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
